MELISSA BARRERA: Open Payments
NPI 1336780543 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,008 in 56 payments from 14 companies in 2025. Trend: 2023 $637 · 2024 $1,432 · 2025 $1,008
Food & beverage: $1,008
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $197 |
| ABBVIE INC. | 16 | $150 |
| E.R. Squibb & Sons, L.L.C. | 5 | $109 |
| Indivior Inc. | 3 | $74 |
| Neurocrine BioSciences, Inc. | 2 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Corium, LLC | 6 | $62 |
| Alkermes, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Lundbeck LLC | 2 | $51 |
Products named: VRAYLAR, FANAPT, COBENFY, REXULTI, SUBLOCADE, INGREZZA, AUSTEDO XR, Azstarys.
Industry payments across FL — which companies pay providers there.
